Method of treating type I diabetes

• US 8,314,080 B2
• Filed: 04/06/2010
• Issued: 11/20/2012
• Est. Priority Date: 04/06/2010
• Status: Active Grant

• Current Assignee: Kuwait University
• Original Assignee: Kuwait University
• Inventors: Al-Saeedi, Fatma Jassab Faleh Marzooq
• Primary Examiner(s): Weddington, Kevin E
• Application Number:
  US12/662,231
• Publication Number:
  US 20110245348A1
• Time in Patent Office: 959 Days
• Field of Search: 514/78, 514/866
• US Class Current: 514/78
• CPC Class Codes: A61K 31/14 Quaternary ammonium compounds, e.g. edrophonium, choline betaines A61K31/205
• CPC Class Codes: A61P 3/10 for hyperglycaemia, e.g. antidiabetics

Abstract

The method of treating type I diabetes includes the treatment of diabetic patients with choline in order to control the patient'"'"'s lipid profile. The treatment method includes the step of administering to the patient a therapeutically effective dosage of choline or a pharmaceutically acceptable salt thereof. In human patients, the effective dosage of choline is preferably approximately 10 mg., delivered daily. Although the choline may be injected in solution, it is preferably delivered orally to the patient.

Claims

1. A method of treating type I diabetes, comprising the step of administering to a patient a therapeutically effective dosage of choline or pharmaceutically acceptable salts thereof for the treatment of type I diabetes, wherein the choline is delivered to the patient in a daily dosage of 10 mg.

2. The method of treating type I diabetes as recited in claim 1, wherein the step of administering to the patient the therapeutically effective dosage of choline includes delivery of the choline to the patient through oral delivery.